Dishman Carbogen Amcis Outperforms Sensex with Strong Long-Term Returns and Bullish Indicators

Dishman Carbogen Amcis Ltd, a small-cap player in the Pharmaceuticals & Biotechnology sector, has shown significant performance metrics today. The stock has increased by 2.76% in a single day, outperforming the Sensex, which rose by only 0.55%. Over the past week, Dishman Carbogen Amcis has gained 2.78%, while the Sensex experienced a slight decline of 0.23%.
In terms of longer-term performance, the company has delivered an impressive 82.48% return over the past year, significantly surpassing the Sensex's 9.49% gain. The stock's performance over the last three years stands at 128.84%, compared to the Sensex's 46.03%, and over five years, it has soared by 280.45%, while the Sensex has increased by 137.53%.

From a technical perspective, the stock exhibits a bullish trend in several indicators, including MACD and Bollinger Bands on both weekly and monthly charts. The current market capitalization of Dishman Carbogen Amcis is Rs 4,329.00 crore, with a P/E ratio of 191.27, notably higher than the industry average of 34.48.